← Leaderboards
John G Kuchtey
Vanderbilt University Medical Center
$2,421,223
Attributed
$2,421,223
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $481.3K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,421,223 · 2
By mechanism
R01$1,939,973 · 1
R21$481,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- David J Calkins$13,258,390
- Petr Baranov$2,384,081
- Lauren Katie Wareham$526,841
Others in their field
Other Emerging Leaders on “Pathology”
- Ted Ross · University Of Georgia$68,763,143
- Dale Sandler · Social And Scientific Systems, Inc.$59,740,435
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
PathologyRetinal Ganglion CellsMutationPathogenicityReceptorExtracellular MatrixLens DislocationMicrofibrilsOptic NervePathogenesisPrimary Open Angle GlaucomaProteinsAxonAnimal ModelAffectGlaucomaBindingMarfan SyndromeBlindnessAdamtsCanis FamiliarisDefectGenesSignal Transduction
Grant awards (6)
ADAMTS10 Regulation of Transforming Growth Factor Beta$481,250
R21 · FY2025 · EY · contact PI
Investigation of ADAMTS in glaucoma pathogenesis$375,352
R01 · FY2021 · EY · contact PI
Investigation of ADAMTS in glaucoma pathogenesis$387,196
R01 · FY2020 · EY · contact PI
Investigation of ADAMTS in glaucoma pathogenesis$387,423
R01 · FY2019 · EY · contact PI
Investigation of ADAMTS in glaucoma pathogenesis$387,644
R01 · FY2018 · EY · contact PI
Investigation of ADAMTS in glaucoma pathogenesis$402,358
R01 · FY2017 · EY · contact PI